Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
The aim of this study was to determine the discriminative value of irisin for acutely decompensated heart failure (ADHF) in type 2 diabetes mellitus (T2DM) patients with chronic HF. We included 480 T2DM patients with any phenotype of HF and followed them for 52 weeks. Hemodynamic performances and th...
Main Authors: | Alexander A. Berezin, Anica Babic Obradovic, Ivan M. Fushtey, Tetiana A Berezina, Michael Lichtenauer, Alexander E Berezin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/10/4/136 |
Similar Items
-
Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
by: Alexander A. Berezin, et al.
Published: (2022-05-01) -
Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
by: Alexander A. Berezin, et al.
Published: (2022-11-01) -
Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
by: Alexander A. Berezin, et al.
Published: (2022-09-01) -
The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
by: Alexander A. Berezin, et al.
Published: (2023-02-01) -
Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
by: Alexander A. Berezin, et al.
Published: (2022-11-01)